Chemours/$CC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Ticker
$CC
Sector
Primary listing
NYSE
Employees
6,000
Headquarters
Website
Chemours Metrics
BasicAdvanced
$2.6B
-
-$2.75
1.59
$0.68
2.03%
Price and volume
Market cap
$2.6B
Beta
1.59
52-week high
$21.72
52-week low
$9.13
Average daily volume
3.9M
Dividend rate
$0.68
Financial strength
Current ratio
1.676
Quick ratio
0.789
Long term debt to equity
1,802.51
Total debt to equity
1,845.607
Interest coverage (TTM)
1.30%
Profitability
EBITDA (TTM)
664
Gross margin (TTM)
18.34%
Net profit margin (TTM)
-7.04%
Operating margin (TTM)
6.00%
Effective tax rate (TTM)
-50.55%
Revenue per employee (TTM)
$980,000
Management effectiveness
Return on assets (TTM)
2.98%
Return on equity (TTM)
-85.27%
Valuation
Price to revenue (TTM)
0.442
Price to book
10.9
Price to tangible book (TTM)
13.67
Price to free cash flow (TTM)
-47.919
Free cash flow yield (TTM)
-2.09%
Free cash flow per share (TTM)
-0.36
Dividend yield (TTM)
3.91%
Forward dividend yield
2.03%
Growth
Revenue change (TTM)
0.62%
Earnings per share change (TTM)
-489.89%
3-year revenue growth (CAGR)
-5.50%
10-year revenue growth (CAGR)
-0.34%
3-year earnings per share growth (CAGR)
-19.91%
10-year earnings per share growth (CAGR)
8.95%
3-year dividend per share growth (CAGR)
-5.74%
What the Analysts think about Chemours
Analyst ratings (Buy, Hold, Sell) for Chemours stock.
Bulls say / Bears say
Chemours, DuPont and Corteva’s settlement of New Jersey PFAS claims for $875 million over 25 years (present value ~$500 million pre-tax) removes a major legacy liability, clearing a path to focus on core businesses (Reuters)
Thermal & Specialized Solutions segment delivered 15% year-over-year net sales growth to $597 million, led by a 65% increase in Opteon™ refrigerant volumes under the U.S. AIM Act transition, driving segment EBITDA up 29% to $207 million (Business Wire)
Adjusted earnings per share of $0.58 in Q2 2025 surpassed the $0.46 consensus estimate, alongside a 4% rise in net sales to $1.6 billion, underscoring improved underlying profitability and operational execution (TradingView)
Net loss of $381 million in Q2 2025, or $2.54 per diluted share, was driven by $257 million of litigation-related charges from the New Jersey PFAS settlement, weighing on reported earnings and cash flows (Business Wire)
Titanium Technologies segment adjusted EBITDA plunged 43% year-over-year to $47 million, with margins collapsing to 7%, due to lower pricing and $15 million in incremental costs from a rail line disruption, highlighting ongoing operational vulnerabilities (Business Wire)
As of June 30, 2025, Chemours carried $4.2 billion in gross debt (net debt $3.7 billion) with a trailing twelve-month net leverage ratio of 4.7x, constraining financial flexibility and increasing interest burden (Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.
Chemours Financial Performance
Revenues and expenses
Chemours Earnings Performance
Company profitability
Chemours News
AllArticlesVideos
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
Business Wire3 weeks ago
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
Business Wire4 weeks ago
Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Chemours stock?
Chemours (CC) has a market cap of $2.6B as of September 16, 2025.
What is the P/E ratio for Chemours stock?
The price to earnings (P/E) ratio for Chemours (CC) stock is 0 as of September 16, 2025.
Does Chemours stock pay dividends?
Yes, the Chemours (CC) stock pays dividends to shareholders. As of September 16, 2025, the dividend rate is $0.675 and the yield is 2.03%. Chemours has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Chemours dividend payment date?
The next Chemours (CC) dividend payment date is unconfirmed.
What is the beta indicator for Chemours?
Chemours (CC) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.